BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 23, 2020
View Archived Issues
Mitochondria, interneurons, cognition link explored
Read More
Huntington's disease found to alter neurodevelopment
Read More
TTX-3360 selected as Triplet's first clinical candidate for repeat expansion disorders
Read More
Potent dual orexin OX1/2 receptor antagonist with improved PK profile for insomnia treatment
Read More
Phase Ib/II study of margetuximab + pembrolizumab in HER2-positive gastroesophageal adenocarcinoma
Read More
Characterization of real-time CAH degradation under pH environment of GI tract using microrheology
Read More
SOCS3 as a new therapeutic target in breast cancer
Read More
RO-7297089 demonstrates target engagement and safety in models of MM
Read More
CSF-1R as novel therapeutic target in 4T1 xenografts
Read More
SPV Therapeutics synthesizes new CDK inhibitors
Read More
Chinese investigators patent P2X3 receptor antagonists
Read More
Integral BioSciences discloses IDH1 mutant inhibitors
Read More
Dana-Farber Cancer Institute describes CDK7 inhibitors
Read More
Janssen Pharmaceutica and Johnson & Johnson present FGFR3 inhibitors
Read More
Signs of efficacy seen with DC-based cryoimmunotherapy ACT-2001 in mCRPC
Read More
Harbour BioMed presents CD73-targeting antibody HBM-1007 for immuno-oncology therapy
Read More
FibroGenesis' PneumoBlast induces reduction of lung fibrosis
Read More
New phase I/II trial explores use of DNL-310 for pediatric patients with Hunter's syndrome
Read More
TAK-676 studied alone and with pembrolizumab in new phase I study for advanced solid tumors
Read More
First phase II study of Lyme disease vaccine candidate VLA-15 meets endpoints
Read More
AdAlta begins treatment in phase I study of AD-214 for interstitial lung disease
Read More
Inotrem cleared to begin phase IIa study of nangibotide in patients with COVID-19
Read More
PTC initiates phase II/III study of PTC-299 in hospitalized participants with COVID-19
Read More
Gan & Lee opens phase Ib/II study of GLR-2007 in advanced solid tumors
Read More
UCB begins first-in-human evaluation of UCB-8600
Read More
